Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prevention

B vitamins and CVD—failure to find a simple solution

The hope that a simple, affordable, and safe homocysteine-lowering intervention with folic acid and vitamin B12 would improve outcomes for patients with established cardiovascular or renal disease has been crushed by the null results from large B-vitamin treatment trials completed to date.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Joseph, J., Handy, D. E. & Loscalzo, J. Quo vadis: whither homocysteine research? Cardiovasc. Toxicol. 9, 53–63 (2009).

    Article  CAS  Google Scholar 

  2. Humphrey, L. L., Fu, R., Rogers, K., Freeman, M. & Helfand, M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin. Proc. 83, 1203–1212 (2008).

    Article  Google Scholar 

  3. Armitage, J. M. et al. for the SEARCH Collaborative Group. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 303, 2486–2494 (2010).

    Article  CAS  Google Scholar 

  4. Clarke, R. et al. for the B-Vitamin Treatment Trialists' Collaboration. Effects of homocysteine-lowering with B-vitamins on cardiovascular disease, cancer and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals (in press).

  5. Cole, B. F. et al. for the Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297, 2351–2359 (2007).

    Article  CAS  Google Scholar 

  6. Ebbing, M. et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12 . JAMA 302, 2119–2126 (2009).

    Article  CAS  Google Scholar 

  7. Hustad, S. et al. The methylenetetrahydrofolate reductase 677C T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am. J. Hum. Genet. 80, 846–855 (2007).

    Article  CAS  Google Scholar 

  8. Lichtenstein, A. H. & Russell, R. M. Essential nutrients: food or supplements? Where should the emphasis be? JAMA 294, 351–358 (2005).

    Article  CAS  Google Scholar 

  9. Refsum, H. et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 136, 1731S–1740S (2006).

    Article  CAS  Google Scholar 

  10. Ebbing, M. et al. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J. Intern. Med. doi: 10.1111/j.1365–27962010.02259.x.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marta Ebbing.

Ethics declarations

Competing interests

P. M. Ueland is a member of the steering board of the nonprofit Foundation to Promote Research into Functional Vitamin B12 Deficiency, and Bevital AS, a company owned by the foundation. M. Ebbing declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebbing, M., Ueland, P. B vitamins and CVD—failure to find a simple solution. Nat Rev Cardiol 7, 608–609 (2010). https://doi.org/10.1038/nrcardio.2010.138

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrcardio.2010.138

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing